You are here

Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
University of South Alabama Division of Clinical Research
Mobile, Alabama, 36617 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Pneumonia, Pneumococcal Vaccines
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Age 50 years and older.

- Presents to a study site with clinically suspected pneumonia.

- Has a radiographic finding that is consistent with pneumonia.

- Able and willing to provide urine.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Transfer to a study hospital after already being hospitalized for 48 hours or more at
any other inpatient facility (such as community hospital).

- Hospital-acquired pneumonia (ie, pneumonia developing 48 hours after hospital
admission).

- Previous enrollment in this study within the past 30 days.

NCT01086397
Pfizer
Completed
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now